Search
When I graduated from pharmacy school over forty years ago I had a vision for a future of pharmacy where pharmacists were recognized and compensated for their knowledge of medication as opposed to the dispensing of medication, and I am very proud of the fact that today, at myMatrixx, I have dozens...
Recently, CompPharma, an industry-leading consulting service that provides valuable insights to both payers and PBMs, released its 2019 Prescription Drug Management in Workers’ Compensation Survey Report. The report collected survey responses from 31 respondents, including clinical personnel and...
We’re excited to announce that later in January, myMatrixx Chief Clinical Officer, Phil Walls, RPh, will be presenting at the 17th Annual National Workers’ Compensation Insurance ExecuSummit. Walls will be joined by The Hartford Chief Medical Officer, Adam Seidner, MD, MPH, for a co-presentation...
Recently, the myMatrixx team submitted presentation proposals for a new professional education program announced by RIMS, the risk management society. The Professional Exchange of Risk Knowledge, or PERK, program is offered at no cost to RIMS chapters to provide informative and educational programming...
The U.S. Food and Drug Administration (FDA) recently released a MedWatch Safety Alert regarding serious concerns around the use of gabapentinoids and the risk of serious breathing problems for patients who have respiratory risk factors, as well as those utilizing opioids or any other medications...
During this year’s National Workers’ Compensation and Disability Conference held in Las Vegas, Nevada, myMatrixx President, Mike Cirillo, Chief Clinical Officer, Phil Walls, and Chief Information Officer, Michael Geis, sat down for an interview regarding one of the most important topics currently...
With an aging population that is increasingly choosing to stay in the workforce past the standard retirement age, new issues are emerging in the field of workers’ compensation and workplace medical management. In light of these trends, myMatrixx has published a new report on this topic, titled “Preparing...
With the launch of myRXAdvocate, we’re excited to provide our most extensive set of tools yet to help our partners ensure positive patient outcomes and reduce treatment costs. To highlight the benefits of this program and provide a deeper understanding of the principle of pharmacovigilance that...
In a new Q&A with Risk & Insurance Magazine, myMatrixx Vice President of Product Development, Hollie Lamboy, shared her thoughts on the important role that electronic prescribing plays in improving outcomes and controlling costs for injured workers. Lamboy stresses in the piece that this...
Speaking in a recent profile with industry news website WorkersCompensation.com, myMatrixx Chief Clinical Officer Phil Walls again shared his thoughts on rising drug costs and how to manage them. Walls is quoted as saying that while extreme price hikes grab headlines, and are an important factor,...